Soru

Zorluk: OrtaImmunizations and Vaccine-Preventable Diseases

A 66-year-old girl is evaluated in the pediatric rheumatology clinic for a routine follow-up. Six months ago, she was diagnosed with systemic juvenile idiopathic arthritis. She is currently maintained on high-dose daily oral prednisone (22 mg/kg/day) and methotrexate. Her disease has been well-controlled on this regimen. Review of her medical chart shows that she received all recommended immunizations during her first two years of life, but she has not attended any preventive care visits since then. It is mid-October. Vital signs and physical examination today are unremarkable. Which of the following vaccines can be safely administered to this patient today? (Select all that apply)

  1. Diphtheria, tetanus, and acellular pertussis (DTaP) vaccineCevap
  2. Inactivated poliovirus vaccine (IPV)Cevap
  3. Inactivated influenza vaccine (IIV)Cevap
  4. D
    Measles, mumps, and rubella (MMR) vaccine
  5. E
    Varicella vaccine
  6. F
    Live-attenuated influenza vaccine (LAIV)

Cevap

The inactivated vaccines—Diphtheria, tetanus, and acellular pertussis (DTaP); Inactivated poliovirus vaccine (IPV); and Inactivated influenza vaccine (IIV)—are safe and indicated.
The correct choices are the inactivated vaccines (DTaP, IPV, and IIV). This patient is on a highly immunosuppressive regimen, including high-dose prednisone (22 mg/kg/day) and methotrexate, which significantly impairs cellular immunity. Inactivated vaccines do not contain live pathogens and therefore pose no risk of causing infection, even in immunocompromised hosts. Because she is due for her 44-to-66-year booster series and it is influenza season, the inactivated options should be administered to provide protection. Although her immunologic response to these vaccines might be blunted compared to a healthy child, the safety profile remains favorable and vaccination is strongly indicated.

Adım Adım Çözüm

1
Identify the patient's current immune status based on her medication regimen.
The patient is considered severely immunocompromised due to the concurrent use of high-dose systemic corticosteroids (22 mg/kg/day of prednisone) and methotrexate.
Determining immune status is the critical first step for evaluating which vaccine formulations are safe.
2
Determine which vaccines the patient is missing based on age and the current season.
At age 66, she is due for her 44-to-66-year catch-up series (which typically includes DTaP, IPV, MMR, and Varicella) and her annual seasonal influenza vaccine.
This establishes the baseline recommended immunization schedule for the patient's age group.
3
Filter the recommended vaccines based on the safety profile for immunocompromised hosts.
Inactivated vaccines (DTaP, IPV, IIV) are safe to give. Live-attenuated vaccines (MMR, Varicella, LAIV) must be withheld.
Live vaccines pose a severe risk of uncontrolled vaccine-strain infection in patients lacking adequate cell-mediated immunity.

Anahtar Kavram

Live-attenuated vaccines are contraindicated in patients receiving significant immunosuppressive therapy, whereas inactivated vaccines can and should be safely administered to provide protection.
Bu soruyu puanla